Phase 4Recruiting

Improving White Blood Cell Collection From Healthy Donors

Collection of Granulocytes by Apheresis of Healthy Donors Stimulated With Filgrastim (G-CSF) and Dexamethasone

Sponsor
National Institutes of Health Clinical Center (CC) (NIH)
Enrolment
1,000 planned
Conditions
Allogeneic Granulocyte Donation
Interventions
Filgrastim; Dexamethasone
Ages
adults, older adults
Registry
NCT01553214

From the registry

Background: \- White blood cells called granulocytes help the body fight infection. People who have had chemotherapy or bone marrow transplants may have very low numbers of these cells. Transfusions of these cells can help improve the body's ability to fight infection. However, most of the cells are located in the bone marrow or spleen, and are hard to collect from healthy donors. Two drugs, filgrastim and dexamethasone, can help move the cells to the bloodstream to be collected by apheresis. Researchers want to study the best ways to collect these white blood cells. They also want to monitor the effects of the injections and donations on the volunteer donors. Objectives: \- To improve the amount and quality of granulocytes (white blood cells) collected by apheresis for donation. Eligibility: \- Healthy volunteers between 18 and 75 years of age. Design: * Participants will be screened with a physical exam and medical history. Initial blood tests will be done to check for eligibility. * Participants will donate granulocytes by apheresis a maximum of 12 times in 1 year.…

Primary outcomes

  • Operational feasibility and impact of managing a volunteer community donor granulocytapheresis program
Full record on ClinicalTrials.gov